月度归档 2025年3月12日

On August 23rd and 24th, the original stand-up comedy competition program "king of comedy Stand-up Season" produced by iQiyi continued wonderfully. After the debut of 44 groups of singles actors, Yang Li’s "only one monopoly program is always bad", Fu Seoul’s online hacking of ex-husbands Liu and Zhang Shuo, Tang Xiangyu’s pre-sale of marriage, and Yu Xiangyu’s philosophical analysis of "financial freedom is real freedom" triggered a collective discussion among netizens. All the resurrection gold medals of the four "Devils" were taken away, and the newcomer’s dark horse is strong and surprising. After two weeks of hot broadcast, because of the intensive treatment of mental hunger, it was praised by netizens as "Internet quality carbohydrate".

"solo flight" Yan Hexiang shouted that 44 groups of actors in Guo Qilin bombed the audience and made their debut on the first stage. The style was diverse

Last week, the program ushered in the second half of the camp firefight. Cross-border stand-up comedy cross talk OG Yan Hexiang finale, full of high energy. He exposed his solo life and made a fancy speech about Guo Qilin. "I’m not here to compete, I’m here to find someone." His burden is constant and his mouth is coherent. The "saying" and "teasing" in cross talk are still used in stand-up comedy, and the audience is still full of laughter. The newcomer Yu Xiangyu’s philosophical interpretation of the sadness of working cattle and horses, self-mockery of "camel Xiangzi", "what Aristotle, more work can get more" and "financial freedom is real freedom" have aroused the resonance of all working people; The former HR door-to-door diss "the boss doesn’t treat interns as people" and "the students are paid by each other" hilariously hit the social pain point; Shi Yan talked about the fact that property management work is similar to playing football. "You don’t need any skills, just be able to resist scolding." I am very funny.

At this point, the initial stage of 44 groups of stand-up comedians ended, and the collective appearance of stand-up comedians with different occupations and styles also made netizens hooked up. Among them, there are mature actors in the comedy industry, such as Liu Yong, Deer and Yan Hexiang, who let everyone see the experience and level after years of stage polishing; There are stand-up comedians who are extremely popular offline, such as Fu Hang, Liang Yan and Menqiang. They can still play online and gain more audiences with their excellent performances. In addition, there are dark horse newcomers such as Liu Rencheng, Qi Qi, Ronaldinho and Yu Xiangyu, with good potential and promising future. In fact, these actors come from all walks of life, including Shi Yan, a property worker, Yan Yan, a grass-roots worker, HR menqiang, pumpkin, forensic doctor Wang Yaofan, rapper Naomi, rock musician Zang Hongfei and so on. Different industries have enriched the diversity of stand-up comedians’ types and styles. Through them, we can gradually see the core of "from little people to king of comedy" and the sincere intention of iQiyi to provide fresh blood for the industry.

"Internet Quality Carbohydrate" deserves its name. The newcomer of Dark Horse won four gold medals in a row, and his performance was eye-catching.

After the broadcast of "king of comedy Stand-up Season", the golden sentence has become a hot topic in major social media, and it is well-deserved to be called "Internet quality carbohydrate". The program really specializes in spiritual hunger, with its dense laughter and frequent golden sentences, which brings infinite "happiness"; Every happy person’s insight into life touches on social issues and is extremely "nutritious"; At the same time, these actors both show "solid" high-level basic skills in performance and rhythm. Netizens have said, "I like the program competition system to avoid the elimination of expert confrontation." "I have always loved stand-up comedy, and I have had a good life this year!"

It is worth mentioning that, following the first phase of Zhou Qimo and Pang Bo’s failure to win the new talent, Wang Jianguo and Yang Li in the "Devil Challenge" also presented the resurrection gold medals successively. As Yang Li said in the paragraph, "For an industry, only a monopoly program is always bad." Only after the wave can stand-up comedy flourish. Iqiyi has always been committed to "innovation". This time, king of comedy Stand-up Season shows the new style and diverse styles, which not only reflects iQiyi’s profound insight and unremitting pursuit in the field of stand-up comedy, but also brings vitality and hope to the industry.

At 12:00 noon on August 30th and 31st, the second stage "Xiaoqiang Challenge" will be held, and Fan Zhiyi, the leader of the atmosphere group, will be pleasantly surprised to join. The actor who likes singles from 32 to 24 is becoming more and more fierce and cruel. Whoever can stand out and who regrets leaving has become a suspense that the audience cares about. Every Friday and Saturday at 12:00, the feature film is updated, locking iQiyi to unlock more fried scenes and surprise moments.

On April 16th, world internet conference Digital Silk Road Development Forum was held in Xi ‘an, Shaanxi. In addition to the opening ceremony and the main forum, world internet conference Member Representative Symposium, Cross-border E-commerce Competitiveness Assessment Seminar and Digital Silk Road Cross-border E-commerce Seminar were also held. Guests from international organizations, governments, enterprises, and academic circles conducted in-depth exchanges and discussions on three topics: "Building Silk Road by Digital Interconnection", "International Cooperation of Silk Road E-commerce" and "Digital Village and Sustainable Development".

The guests at the meeting said that with the deepening of global exchanges and cooperation, the importance of interconnection has become increasingly prominent. The Digital Silk Road has provided us with unprecedented opportunities and opened up new paths for technological innovation and economic growth. It is hoped that this forum will be used as a platform to seize good cooperation opportunities, strengthen dialogue and exchanges, deepen pragmatic cooperation, and jointly promote the high-quality development of digital Silk Road to a new stage.

E-commerce helps build a digital silk road.

The construction of the Digital Silk Road is an important measure to conform to the development trend of the digital economy era, an important contribution of China to the development and governance of the global digital economy, and an important part of building the "Belt and Road" with high quality.

In recent years, China has vigorously promoted the construction of the Digital Silk Road and actively expanded and deepened international cooperation. Li Qingshuang, vice president of the China Council for the Promotion of International Trade, said that by October 2023, China had signed memorandums of cooperation on e-commerce with 30 countries and established bilateral cooperation mechanisms on e-commerce. Silk Road E-commerce has shown strong resilience and vitality and has become a golden business card for building the Belt and Road Initiative with high quality.

World internet conference Digital Silk Road Development Forum. Photo by Li Xiaoyin, China Netcom

At present, the century-old changes have accelerated the evolution, global trade and investment have slowed down, the international situation has undergone profound and complex changes, and the world has entered a new period of turmoil and change. As a new format and mode of e-commerce, cross-border e-commerce has developed rapidly in recent years and has become a new engine and a new bright spot of global economic development.

The world internet conference Cross-border E-commerce Practice Case Collection (2024) released at this forum fully demonstrates the beneficial experience of governments at all levels, social organizations and all links in the industrial chain in promoting the healthy development of cross-border e-commerce, actively exploring and continuously innovating, and creating a good business environment, so as to promote cross-border e-commerce related entities around the world to learn from each other and complement each other’s advantages, and help to form a business environment that promotes the healthy development of cross-border e-commerce.

As one of the cases, the Silk Road Media E-commerce Trade Exchange Platform faces Central Asia and the Belt and Road region, and builds a communication matrix of "Silk Road Video Media+Silk Road Audio Media+Silk Road New Media" to promote the linkage with overseas media content. At the same time, relying on the technical support system of the media e-commerce platform, it builds a trade exchange platform, integrates resources from various regions, and actively promotes international exchanges and cooperation.

Technology empowerment promotes inclusive sharing of digital dividends.

The changes in the world, the times and the history are unfolding in an unprecedented way, and the global digitalization, networking and intelligence are advancing in depth, which has brought a series of new challenges to human economic and social development. It is a common mission and task for all countries in the world to build a more inclusive and convenient digital society and make digital technology better benefit society and people all over the world.

In recent years, Internet technology has developed rapidly. However, there are still huge differences between developed and developing countries, between urban and rural areas, and between regions. There are still about 2.6 billion people in the world who do not have access to the Internet. Houlin zhao, former Secretary-General of the International Telecommunication Union, called on all parties to work together to eliminate digital poverty and digital divide and enhance human welfare, especially to make better use of technologies such as 5G, big data and artificial intelligence, eliminate the "access gap", "use gap" and "capability gap" and jointly build a community of cyberspace destiny.

As an important part of the Belt and Road Initiative, the Digital Silk Road has played an important role in enhancing digital connectivity and community capacity building, bridging the digital divide and promoting sustainable development in the past 10 years. Besik Buggiani Shvili, CEO and Chairman of the Board of Directors of the Georgian Development Foundation, firmly believes that the Digital Silk Road Initiative has brought great opportunities for multilateral cooperation and prosperity.

The achievements of digital technology development should be shared by people all over the world, so as to promote regional coordinated and sustainable development through digitalization, which is also the proper meaning of building the digital Silk Road.

At present, the new infrastructure of 5G is accelerating development on a global scale. Si Han, president of Global Association for Mobile Communications Greater China, said that along the Digital Silk Road, the development speed of markets in different regions is different. Developed 5G markets, such as China, North America and Gulf countries, are in a leading position in 5G applications. However, in emerging markets, 5G has just started and has huge development space.

On the other hand, regarding the application of digital technology in emergency rescue, Sterling, Personal Envoy of the President of the International Committee of the Red Cross for China Affairs and Director of the East Asian Regional Representative Office, listed some situations, such as finding missing persons through digital matching; Mine detection through the combination of artificial intelligence and unmanned aerial vehicle; Using satellite technology and artificial intelligence to monitor the impact of natural disasters such as floods and droughts, so as to give more accurate material assistance; Use drones, infrared cameras, etc. to search for mineral deposits.

World internet conference Digital Silk Road Development Forum. Photo by Li Xiaoyin, China Netcom

Work hand in hand to build a community of cyberspace destiny

This year marks the beginning of a new decade to jointly build the Belt and Road Initiative. World internet conference held the Digital Silk Road Development Forum for the first time, which is an innovative move to promote digital technology to build the "Belt and Road" with high quality. It aims to inherit the spirit of Silk Road, gather the wisdom of all parties, and actively build a new platform to promote global exchanges and cooperation.

Digital Silk Road is not only a channel for trade and economic exchanges, but also a link for cultural communication. Yeddin, deputy director of the Propaganda Department of Myanmar, said that the Digital Silk Road shows great potential for transforming social and economic development, and at the same time expresses the common vision of promoting economic growth, cultural understanding and regional development through technology.

Educational exchanges have built a solid bridge for the people of all countries along the "Belt and Road" and witnessed the unremitting pursuit of interconnection and cultural mutual learning by people of all countries. In order to promote the combination of digital technology and excellent traditional culture, and promote digital cultural exchange, the Ministry of Education of China initiated the implementation of the national education digitalization strategy, launched the national public service platform for smart education, and built it into the world’s largest online learning platform, with more than 2.8 billion visitors and users covering more than 200 countries and regions around the world.

At the forum, UN Under-Secretary-General Li Junhua said that the UN will adopt a global digital compact at its future summit in September this year as a framework for the principle of digital sharing. It will support collaborative work in digital progress and cooperation, including active interconnection, data governance and digital risk reduction.

Dinggumuzi Bodhi, Deputy Minister of Information and Communication Technology and Postal Express Service of Zimbabwe, said that the digital Silk Road has provided unprecedented opportunities for promoting cross-border cooperation and promoting sustainable development. By strengthening digital interconnection and cooperation, a more inclusive world will be built, which will open the way for the common prosperity of future generations and have a far-reaching impact on promoting the building of a community of human destiny. (Written by: Chen Jindan Mi Jiangyan))

1905 movie network news　 According to the data of Lighthouse Professional Edition, as of 11: 42 on February 14th, the Spring Festival in 2024 (February 10th — February 17) The total box office (including pre-sales) of the schedule exceeded 5 billion! Temporarily list the top three at the box office.

So far, the number of people watching movies in the Spring Festival in 2024 has exceeded 100 million, and the number of people watching movies in the Spring Festival has exceeded 100 million for six consecutive years.

YOLO, who directed and starred in the film, continued to lead the 2024 Spring Festival with a box office of 1,718.5 million, with a cumulative attendance of over 33.8 million. As of February 13th, the film has become the box office champion in the first half of the 2024 Spring Festival.

Directed by,,, and other films starring "Pegasus 2" temporarily ranked second with a box office of 1,508.6 million, and the competition with YOLO is fierce, and these two films have been significantly ahead of other films.

The animated film "Boonie Bears: Time Twist" has accumulated 895 million yuan at the box office, ranking third for the time being. This year is the tenth consecutive year that this series of animated films has been in the Spring Festival, and it is still welcomed by many friends of all sizes, and its reputation has not diminished and its momentum is strong.

Directed, starring,,,, etc., the cumulative box office reached 710 million yuan, and the single-day box office on February 13 was 142.7 million, which was 142.6 million more than that on February 12, and the box office fell for two consecutive days.

Temporarily ranked fifth and sixth, the box office was 78,741,200 and 71,747,600 respectively. Both films were affected by the film arrangement, and the box office performance was temporarily behind, but the film’s reputation was acceptable and it was recognized by many audiences.

Special feature of 1905 film network A bowl of "ecstasy rice" and a "peeing cow pill" saved the hero who was at the bottom of his life — — Stephen Chow also saved his precarious acting reputation.

After a lapse of 28 years, the film will soon land in the mainland cinema on August 31. Let’s go back to 1996 with Professor Suo Yabin of China Communication University, and see what kind of inner monologue Stephen Chow hides in The God of Food, and how it makes Stephen Chow return to the peak, from "Star Boy" to "Star Master".

Stephen Chow: Life from Greasy to Vicissitudes

The God of Food is known as Stephen Chow’s "semi-autobiographical film". The hero Stephen Chow not only has the same English name as Stephen Chow, but also has a similar life experience as Stephen Chow 28 years ago.

At the beginning of the film, Steven Chow subverts Stephen Chow’s previous screen image. He is a greasy and successful middle-aged man, and after the selection meeting of the God of Food, he lambasted the chefs for their incompetence.

After experiencing the ups and downs of life, Stephen Chow is full of silver hair and is full of vicissitudes. This model became a classic image that Stephen Chow appeared in the public eye after, which is also his self-understanding of his middle-aged image.

Before filming "The God of Food", Stephen Chow set up his own business, suffered losses in investing in filming, and refused the request of the film producer for a pay cut, and was labeled as "playing big cards" for a time. Before the release of Gourmet, the media reported gloating and bluntly said, "Stephen Chow eats porridge and depends on Gourmet.

Suoyabin:Stephen Chow may have put a lot of bitterness and frustration in his life into "The God of Food". The changes in his style in the film also reflect Stephen Chow’s self-orientation.

Gourmet vs

From unwilling to open-minded

The God of Food and king of comedy are important turning points in Stephen Chow’s acting career. In Stephen Chow’s creative sequence, these two films are the two works that can best express his personal life experience.

Suoyabin:These two works have a sense of yin and yang. The two awards in "The God of Food" are all manipulated by shady people, which directly expresses Stephen Chow’s dissatisfaction with the awards of the Hong Kong Film Awards. This is even more obvious in the previous films co-directed by Stephen Chow.

But this "bitterness" disappeared in king of comedy three years later. Perhaps because it has spread in the mainland at this time, Stephen Chow has been recognized by the audience again, or even further, perhaps because he has put down his obsession with awards, and he has been open-minded at this time. It doesn’t matter whether I succeed in the secular sense or not if I insist on my love and find my own stage in king of comedy. Stephen Chow’s understanding of life is also much more open-minded: if I want to regain the recognition of the audience, I must recognize this normal heart.

A mixture of joy and sadness: from Star Boy to Star Master

There are some golden sentences in many of Stephen Chow’s works, such as "Everyone is a god of food with his heart" in "God of Food" and "Everything is dark in front of him" in "king of comedy". No, it will be beautiful after dawn. " These golden sentences are full of joy on the surface, but in fact they are taking pains.

Suoyabin:There is a mixed feeling in Stephen Chow’s films. He successfully mixes the humble, the small, the great, the lofty, the sad and the happy. Don’t let the audience immerse themselves in a certain emotion for too long, but let people keep spinning in this complicated emotion. For example, in "king of comedy", Yin Tianchou (Stephen Chow) and Liu Piaopiao (Liu Piaopiao) watch the scenery at night, but there is nothing in front of them, and they have to comfort themselves there. But if we think about it, it is precisely because we have to work during the day to make money that we choose to enjoy the scenery at night.

The core of comedy is tragedy, and to a certain extent, Stephen Chow also achieved this. Starting from The Gourmet, Stephen Chow’s series of director’s works have shifted from label-based features to insight into human nature, which is also an important turning point for Stephen Chow from "Star Boy" to "Star Master".

Although Stephen Chow is no longer prolific, it seems that the voice waiting for his new works is still the more mainstream voice in the audience.

Then, why do we go to the cinema to watch an old movie "The God of Food"?

Suoyabin:This may have a variety of mentality, for example, to "Star Master" a movie ticket, or like me, I especially want to see how expressive the "God of Food" is on the big screen. Take a look at how Stephen Chow, who wants to transform in middle age but is still facing troubles, gropes her way forward in a desperate situation.

　　Lanzhou Intermediate People’s Court of Gansu Province

　　Criminal verdict

　　(2020) Gan 01 was sentenced to No.37.

　　The original public prosecution organ is the People’s Procuratorate of Yuzhong County, Gansu Province.

　　Appellate unit (defendant in the original trial) Gansu Yalan Pharmaceutical Co., Ltd., unified social credit code 91620123745890028F, domicile: No.148, Gongmao Street, heping town, Yuzhong County, and legal representative Dong Wanyou.

　　Litigation representative Li, male, Han nationality, born on September 5, 1969, is the general manager of Gansu Yalan Pharmaceutical Co., Ltd. and lives in Chengguan District of Lanzhou City.

　　Defender Xie Yanren, lawyer of Gansu Qiming Law Firm.

　　Appellant (defendant in the original trial) Peng Mou, male, Han nationality, born on December 28, 1968, with a university education, is from Chengguan District, Lanzhou City, Gansu Province, and is the director of the third marketing department of the sales management center of Gansu Yalan Pharmaceutical Co., Ltd., living in Chengguan District, Lanzhou City. On April 14, 2017, he was released on bail pending trial by Yuzhong County Public Security Bureau on suspicion of producing and selling counterfeit drugs. On January 2, 2018, he was released on bail pending trial by Yuzhong County People’s Procuratorate.

　　Defender An Aiming, lawyer of Gansu Sailai Law Firm.

　　The People’s Court of Yuzhong County of Gansu Province tried the case that the People’s Procuratorate of Yuzhong County of Gansu Province accused the defendant Gansu Yalan Pharmaceutical Co., Ltd. (hereinafter referred to as Yalan Pharmaceutical Co., Ltd.) and the defendant Peng Mou of committing the crime of producing and selling counterfeit drugs, and made a criminal judgment of (2019) Gan 0123 Chu No.51 on November 28, 2019. After the verdict was pronounced, both the defendant Yalan Pharmaceutical Co., Ltd. and the defendant Peng Mou in the original trial refused to accept it and filed an appeal. Our court appealed according to law. The trial is now over.

　　The judgment of Yuzhong County People’s Court in Gansu Province found that:

　　In 2009, the defendant Peng went to work in Yalan Pharmaceutical Company, engaged in the procurement and sales of Chinese herbal medicines. On March 25th, 2015, the defendant Peng was appointed by Yalan Pharmaceutical Company as the Director of Marketing Department 3 of the Sales Management Center, responsible for the raw material procurement, processing and finished product sales of Chinese herbal pieces.

　　In February 2014, the defendant Pengmou purchased 3.2 kg of raw materials of Rhizoma Drynariae from Lanzhou Yellow River Market, and put into production 3 kg of Chinese herbal pieces of Rhizoma Drynariae with batch number of 140201 on February 8, at the price of 28 yuan per kg. This batch of Chinese herbal pieces was sold to Gansu Longyou Pharmaceutical Logistics Co., Ltd. on April 14, 2015. On August 18th, 2015, the Food and Drug Administration of Chengguan District, Lanzhou City sampled the batch of Chinese herbal pieces of Rhizoma Drynariae from Gansu Longyou Pharmaceutical Logistics Co., Ltd., and on October 12th, 2015, it was inspected by Lanzhou Food and Drug Inspection Institute, and the conclusion was: according to the 2015 edition of China Pharmacopoeia, it was inconsistent with the control and did not meet the requirements.

　　In May 2016, the defendant Peng purchased 100 kilograms of raw materials of Peucedanum chinense, and on May 7, he processed and produced 97 kilograms of Chinese herbal pieces of Peucedanum chinense with the batch number of 160501, with the pre-sale price of 26 yuan per kilogram. On October 21, 2016, Lanzhou Food and Drug Administration made a random inspection of this batch of Radix Peucedani Chinese herbal pieces. On December 9, 2016, it was inspected by Lanzhou Food and Drug Inspection Institute, and the conclusion was: according to the 2015 edition of China Pharmacopoeia, it was inconsistent with the control and did not meet the requirements. On December 21, 2016, Lanzhou Food and Drug Administration seized the batch of Radix Peucedani decoction pieces according to law. On January 23, 2017, it was reinspected by Gansu Institute for Drug Inspection, and the conclusion was: According to the "Processing Standard of Traditional Chinese Medicine in Gansu Province (2009 Edition)", the result was Peucedanum, and the non-medicinal parts accounted for 19%, which did not meet the requirements.

　　In June 2015, the defendant Peng bought 12 kilograms of raw materials of Taxilli from Anhui Bozhou Medicinal Materials Market. On May 5, 2016, he put in 11 kilograms, produced and processed 10 kilograms of Chinese herbal pieces of Taxilli with batch number 160501, and passed the self-inspection on May 7. On October 11th, it was sold to Jilin Luwang Pharmaceutical Company with 5 kg of 13 yuan per kg; Sales to Jilin Qixingshan Pharmaceutical Co., Ltd. 3 kg, 11 yuan per kg. On May 5, 2017, Lanzhou Food and Drug Inspection Bureau made a random inspection of the Chinese herbal pieces. On May 27, 2017, it was inspected by Lanzhou Food and Drug Inspection Bureau, and the conclusion was that it was not consistent with the control and did not meet the requirements according to the 2015 edition of China Pharmacopoeia. On July 31, 2017, it was reinspected by Gansu Institute for Drug Inspection, and the conclusion was that according to China Pharmacopoeia (2015 edition), the results did not meet the requirements (with the characteristics of mistletoe).

　　On April 25, 2018, Lanzhou Food and Drug Administration organized relevant experts to identify the Inspection Report of the above-mentioned Chinese herbal pieces. The conclusion was: To determine the authenticity of this batch of drugs, it is necessary to check the production enterprise. If the enterprise has been registered and filed in our province in accordance with relevant laws and regulations, it has the qualification to produce and process "Big Leaf Rhizoma Drynariae", and it is not realized in our province. If there is no qualification to produce and process "Rhizoma Drynariae with big leaves", it is suggested to treat it as fake medicine. For Radix Peucedani with batch number 160501, the supervision unit should further check the registration of the drug manufacturer to see if it has the qualification to produce and process "hard Radix Peucedani". If it has the qualification, it is suggested to treat it as inferior drug, and urge the drug manufacturer to correct the name of the product and punish it according to the relevant provisions of GMP/GSP. If there is no qualification, and because "Peucedanum rigidum" belongs to the variety recorded in the standard of traditional Chinese medicine in Gansu Province, the enterprise is beyond the scope of processing and operation, it will be handled in accordance with the relevant provisions of GMP. Taxilli with batch number 160501 is suggested to be treated as fake medicine.

　　On October 11, 2019, Gansu Provincial Drug Administration replied to the questions involved in this case: (1) Yalan Pharmaceutical Co., Ltd. has the production qualification for the production of Chinese herbal pieces of Rhizoma Drynariae, Radix Peucedani and Herba Taxilli. Drynaria macrophylla was not included in Pharmacopoeia of China (2015 edition), Processing Standard of Traditional Chinese Medicine in Gansu Province (2009 edition) and Standard of Traditional Chinese Medicine in Gansu Province (2009 edition). (2) Gansu Institute of Drug Inspection found that the results of Chinese herbal medicine Qianhu were "hard Qianhu", which was recorded in Gansu Province Chinese Medicine Processing Standard (2009 edition) and Gansu Province Chinese Herbal Medicine Standard (2009 edition), and can be used instead of Qianhu in hospitals, pharmacies and other dispensing departments and retail pharmacies in our province. Does not belong to the current "Drug Administration Law of People’s Republic of China (PRC)" Article 48, paragraph 2, item 2, of the situation of passing off other drugs as such drugs. Gansu Provincial Institute of Drug Inspection found that Taxilli, a traditional Chinese medicine decoction piece, has the characteristics of mistletoe, which belongs to the situation that other drugs are passed off as this drug as stipulated in Item 2, Paragraph 2, Article 48 of the Drug Administration Law of People’s Republic of China (PRC). Viscum mistletoe is also recorded in China Pharmacopoeia (2015 edition), and its "function and indication" are consistent with those of Taxilli, so it is interoperable in clinical use.

　　The above facts were confirmed by the following evidence:

　　(1) Documentary evidence

　　1. The source of the case, the transfer of suspected criminal cases by Lanzhou Food and Drug Administration, the brief introduction of the case, and the notice of case transfer review by Lanzhou Public Security Bureau confirmed that on March 8, 2017, Lanzhou Food and Drug Administration transferred the case that Yalan Pharmaceutical Company was suspected of producing and selling fake Chinese herbal pieces of Qianhu and Rhizoma Drynariae to Yuzhong County Public Security Bureau; On November 9, 2017, Lanzhou Public Security Bureau transferred the case that Yalan Pharmaceutical Company was suspected of producing and selling fake medicine Taxilli to Yuzhong County Public Security Bureau.

　　2. The business license, organization code certificate, drug production license, trademark registration certificate, tax registration certificate, license for purchasing Chinese herbal medicines exclusively, customs declaration registration certificate of consignor and consignor of import and export goods, and drug GMP certificate of Yalan Pharmaceutical Company confirm that Yalan Pharmaceutical Company is a legally registered company with the organization code of 74589002-8, which is a member of China Commodity Bar Code System, engaged in purchasing Chinese herbal medicines, and allowed to produce Chinese herbal medicines and medicines with Chinese herbal medicines.

　　3. The notice of appointment of Yalan Pharmaceutical Company confirmed that Peng was appointed as the marketing director of the sales management center of Yalan Pharmaceutical Company on March 25th, 2015.

　　4. The production record, sales list, acceptance receipt of Gansu Longyou Pharmaceutical Logistics Co., Ltd. and sampling flow of traditional Chinese medicine decoction pieces of Yalan Pharmaceutical Company confirmed that on February 8, 2014, Yalan Pharmaceutical Company produced 3 kg of cannon bone fragments with batch number of 140201. On April 14th, 2015, Yalan Pharmaceutical Co., Ltd. produced 3 kilograms of Rhizoma Drynariae with batch number of 140201 and sold it to Gansu Longyou Pharmaceutical Logistics Co., Ltd. at the price of 28 yuan per kilogram. On May 7, 2016, Yalan Pharmaceutical Co., Ltd. produced 97 kg of Radix Peucedani with batch number 160501. On May 5, 2016, Yalan Pharmaceutical Company produced 10 kilograms of Taxilli with batch number 160501, which was sold to Jilin Luwang Pharmaceutical Co., Ltd. on October 11, 2016 with 5 kilograms of 13 yuan per kilogram, and on November 15, 2016, it was sold to Jilin Qixingshan Pharmaceutical Co., Ltd. with 3 kilograms of 11 yuan per kilogram.

　　5. The inspection report of Yalan Pharmaceutical Co., Ltd. confirmed that on February 18th, 2014, the company made a self-inspection of the production batch No.140201, and the results met the requirements according to the China Pharmacopoeia 2010. On May 7, 2016, the company conducted a self-inspection on the Peucedanum chinense with the batch number of 160501, and the results met the requirements. On May 5, 2016, the company carried out a self-inspection of Taxilli parasitica with the production batch number of 160501. The results showed that this product was tested according to the China Pharmacopoeia (2015 edition), and the results met the requirements.

　　6. Receipt confirmation: On January 10th, 2014, Yalan Pharmaceutical Company purchased 3.2kg of Rhizoma Drynariae from Ma, and the unit price was 20 yuan. On June 6th, 2015, Yalan Pharmaceutical Company purchased 12kg of Taxilli at a certain place in Cheng, and the unit price was 10 yuan.

　　7. The written decision of administrative punishment and the receipt of fines and confiscations from Lanzhou Chengguan Food and Drug Administration confirmed that on July 18th, 2016, Lanzhou Chengguan Food and Drug Administration purchased the inferior medicine of bone fracture and tonic from Yalan Pharmaceutical Company for Gansu Longyou Pharmaceutical Logistics Co., Ltd. for sale. An administrative penalty of 362.7 yuan was imposed, and the company has paid the fine.

　　(2) Testimony of witnesses

　　1. The testimony of Chang (the marketing staff of Yalan Pharmaceutical Company) and Dong (the sales department of Yalan Pharmaceutical Company) confirmed that Peng was mainly responsible for the procurement and production of raw materials for marketing three Chinese herbal medicines and the sales of finished Chinese herbal pieces. The main work of the sales department is the processing and sales of Chinese herbal pieces. Our department is fully responsible for the procurement, production and sales of Chinese herbal medicines, and the quality of finished Chinese herbal medicines is inspected by the company’s quality assurance department. Sales department 3 produces and sells according to the order. After receiving the order, raw materials are purchased first, and the raw materials are processed after passing the quality inspection. On October 21, 2016, Lanzhou Food and Drug Administration randomly sampled one kilogram of finished Peucedanum praeruptorum, which was found to be inconsistent with the provisions of the National Pharmacopoeia and was suspected of producing counterfeit drugs. Later, it was sent to Gansu Provincial Institute for Drug Control, and this batch of Chinese medicinal materials of Peucedanum praeruptorum did not meet the processing specifications of Chinese medicinal materials in Gansu, and was characterized as hard Peucedanum praeruptorum. Traditional Chinese medicine for Rhizoma Drynariae was found by Lanzhou Food and Drug Administration from Gansu Longyou Pharmaceutical Logistics Co., Ltd. to be non-compliant, and was later tested by Lanzhou Food and Drug Inspection Institute, which did not meet the requirements of China Pharmacopoeia. These two batches of drugs all passed the self-inspection.

　　2、杨某(甘肃陇邮医药物流股份有限公司采购总监)的证言证实：2015年4月16日，甘肃陇邮医药物流股份有限公司从亚兰药业公司采购了一批次的骨碎补中药材，批号是140201，总共3公斤，采购价是84元，这批中药材是经亚兰药业检验合格才采购的，最后分发给公司下属的药店销售。兰州市城关区食药局2015年6月26日抽检了该批中药材，检验报告是不符合规定，2016年7月14日对甘肃陇邮医药物流股份有限公司作出行政处罚。2015年10月接到检验报告后甘肃陇邮医药物流股份有限公司对该批药品召回处理。

　　3. The testimony of Zhang (the person in charge of quality assurance department of Yalan Pharmaceutical Company) confirmed that Yalan Pharmaceutical Company started the inspection according to the standard of China Pharmacopoeia from the purchase of raw materials, and then entered the next production link after passing the inspection. After being processed into Chinese herbal pieces, the finished products were inspected, and the batches of drugs were sampled according to the standard for inspection, which was divided into factory inspection and factory inspection. The peucedanum and hard peucedanum sampled by Yalan Pharmaceutical Company are sold only after passing the self-inspection by their own quality inspection department.

　　4. The testimony of Li (general manager of Yalan Pharmaceutical Co., Ltd.) confirmed that Peng’s third marketing department took office on March 25, 2015. Mainly responsible for the procurement, production and product sales of raw materials. He is solely responsible for the procurement, production and sales of Chinese herbal medicines, and is responsible for all the affairs of Chinese herbal medicines in the company according to the needs of production. If there are any problems with the procurement, processing and sales of Chinese herbal medicines, he is entirely responsible for them, and the quality of finished Chinese herbal medicines is inspected by the quality assurance department of the company. The raw materials of parasitic loranthus that failed the sampling inspection were purchased by the department in charge of Peng, and all the medicines passed the self-inspection.

　　(3) Appraisal opinions

　　1. The drug inspection report of Lanzhou Food and Drug Inspection Institute confirmed: On October 12, 2015, the Rhizoma Drynariae (Canned Rhizoma Drynariae) with batch number of 140201 produced by Yalan Pharmaceutical Company was inspected, and there were two large vascular bundles in the center of about 62% of the section, which were crescent-shaped, which did not meet the requirements; The thin-layer chromatography is inconsistent with the control and does not conform to the regulations. Conclusion: This product was tested according to China Pharmacopoeia (2010 edition), and the results did not meet the requirements.

On December 9, 2016, the Peucedanum Peucedanum with batch number 160501 produced by Yalan Pharmaceutical Company was tested, and the conclusion was that this product was tested according to China Pharmacopoeia 2015, which was inconsistent with the control, and the result did not meet the requirements. On May 5, 2017, the batch number of Taxilli parasitica produced by Yalan Pharmaceutical Company was 160501, and the conclusion was that this product was tested according to China Pharmacopoeia 2015, which was inconsistent with the control and the result did not meet the requirements.

　　2. The inspection report of Gansu Institute of Drug Inspection confirmed that on January 23, 2017, the Peucedanum praeruptorum with batch number of 160501 produced by Yalan Pharmaceutical Company was reinspected, and the conclusion was that this product was tested according to the Standard for Processing Traditional Chinese Medicine in Gansu Province (2009 edition), and the conclusion was that Peucedanum praeruptorum was hard, with non-medicinal parts accounting for 19%, which did not meet the requirements. On July 31st, 2017, the batch number of Taxilli produced by Yalan Pharmaceutical Company was 160501, and the conclusion was: according to China Pharmacopoeia 2015, the results did not meet the requirements (with the characteristics of mistletoe).

　　3. Lanzhou Food and Drug Administration’s reply to the Application for Identification of Chinese Herbal Pieces such as Rhubarb confirmed that on April 25, 2018, the bureau set up a "Drug Identification Expert Database" and organized relevant experts to identify the Inspection Report of Chinese Herbal Pieces such as Rhubarb. The conclusion is that the batch number of Rhizoma Drynariae is 140201, and the manufacturer needs to be verified to determine the authenticity of this batch of drugs. If the enterprise has been registered and put on record in our province in accordance with relevant laws and regulations, has the qualification to produce and process "Daye Rhizoma Drynariae", and has been produced, processed and transshipped in our province, but it has not been corrected, it will be handled in accordance with the relevant provisions of GMP/GSP. If there is no qualification to produce and process "Rhizoma Drynariae with big leaves", it is suggested to treat it as fake medicine. For Radix Peucedani with batch number 160501, the supervision unit should further check the registration of the drug manufacturer to see if it has the qualification to produce and process "hard Radix Peucedani". If it has the qualification, it is suggested to treat it as inferior drug, and urge the drug manufacturer to correct the name of the product and punish it according to the relevant provisions of GMP/GSP. If there is no qualification, and because "Peucedanum rigidum" belongs to the variety recorded in the standard of traditional Chinese medicine in Gansu Province, the enterprise is beyond the scope of processing and operation, it will be handled in accordance with the relevant provisions of GMP. Taxilli with batch number 160501 is suggested to be treated as fake medicine.

　　4. The reply from Gansu Provincial Drug Administration confirmed that: (1) Yalan Pharmaceutical Company has the production qualification to produce Chinese herbal pieces of Rhizoma Drynariae, Radix Peucedani and Herba Taxilli. Drynaria macrophylla was not included in Pharmacopoeia of China (2015 edition), Processing Standard of Traditional Chinese Medicine in Gansu Province (2009 edition) and Standard of Traditional Chinese Medicine in Gansu Province (2009 edition). (2) Gansu Institute of Drug Inspection found that the results of Chinese herbal medicine Qianhu were "hard Qianhu", which was recorded in Gansu Province Chinese Medicine Processing Standard (2009 edition) and Gansu Province Chinese Herbal Medicine Standard (2009 edition), and can be used instead of Qianhu in hospitals, pharmacies and other dispensing departments and retail pharmacies in our province. Does not belong to the current "Drug Administration Law of People’s Republic of China (PRC)" Article 48, paragraph 2, item 2, of the situation of passing off other drugs as such drugs. Gansu Provincial Institute of Drug Inspection found that Taxilli, a traditional Chinese medicine decoction piece, has the characteristics of mistletoe, which belongs to the situation that other drugs are passed off as this drug as stipulated in Item 2, Paragraph 2, Article 48 of the Drug Administration Law of People’s Republic of China (PRC). Viscum mistletoe is also recorded in China Pharmacopoeia (2015 edition), and its function and indications are consistent with those of Taxilli, so it is interoperable in clinical use.

　　(4) transcripts of on-site inquests and inspections

　　Records of on-site inspection and photos, and records of seizure and detention confirmed that Lanzhou Food and Drug Administration inspected the drugs produced by Gansu Yalan Company, and seized and detained Rhizoma Drynariae, Radix Peucedani and Herba Taxilli.

　　(5) confessions of the defendant

　　The confession of the defendant Peng confirmed: I am responsible for the acquisition, processing and sales of Chinese herbal medicines in Yalan Pharmaceutical Company, and now I am the sales manager of the company. At the end of 2016, Lanzhou Food and Drug Administration randomly sampled the Chinese herbal medicines Rhizoma Drynariae and Radix Peucedani produced by our unit. The Radix Peucedani was tested by Lanzhou Food and Drug Inspection Institute according to China Pharmacopoeia (the first part of 2015 edition), and the conclusion was inconsistent with the control and did not meet the requirements. After the re-inspection by Gansu Institute for Drug Inspection, according to the Standard for Processing Traditional Chinese Medicine in Gansu Province (2009 edition), it was determined that the Chinese herbal medicine produced by our company was Peucedanum rigidum, and the non-medicinal part accounted for 19%, which did not meet the requirements. Peucedanum praeruptorum is a standard term collected in China Pharmacopoeia. Peucedanum praeruptorum is produced in Gansu Province, mainly because of its different characters, but Peucedanum praeruptorum conforms to the standard of Gansu Province’s Processing Standard of Traditional Chinese Medicine (2009 edition). Peucedanum praeruptorum used in this batch of products of our company conforms to the standard of Gansu Province, and 19% of it refers to the stem of Peucedanum praeruptorum. I know that the stem of Peucedanum Peucedanum is a non-medicinal part, which is considered as an impurity in the standard of processing decoction pieces, but we control it within the allowable range. In March 2016, I bought the raw materials of Peucedanum in Hebei Anguo Medicinal Materials Market, with a total of 100 kilograms per kilogram of 20 yuan. On May 7th, 2016, it was produced and processed into 97kg of Chinese medicinal materials of Radix Peucedani. This batch of medicine was produced according to the company’s production plan. The batch number of this batch of medicine was 160501, and the cost price was 26 yuan per kilogram. Now it is not sold, and it was detained by Lanzhou Food and Drug Administration in the company’s warehouse.Our company’s Rhizoma Drynariae was tested according to the standard of China Pharmacopoeia (2015 edition), and the results did not meet the requirements. Drynaria fortunei was put into production by our company on February 8, 2014. The original medicinal materials were purchased from the Yellow River Market in Lanzhou. At that time, 3.2 kilograms of the original medicinal materials were purchased, and 3 kilograms of the finished Chinese medicinal materials were processed and produced. The batch number was 140201. These 3 kilograms of Chinese medicinal materials were wholesale to Gansu Longyou Pharmaceutical Logistics Co., Ltd., with a total of 84 yuan per kilogram of 28 yuan. The raw materials of Taxilli parasitica produced and sold by our company were purchased in June 2015 in Haozhou, Anhui Province, with a total purchase of 12kg at the unit price of 10 yuan. On May 5th, 2016, 11kg of raw materials were put in, and processed into 10kg of Chinese herbal pieces. On May 7th, the quality inspection department of our unit passed the self-inspection and released for sale. On October 11th, it sold 5kg of 13 yuan to Jilin Luwang Pharmaceutical Co., Ltd., and on November 15th, it sold 3kg of 11 yuan to Jilin Qixingshan Pharmaceutical Co., Ltd. This year, the Food and Drug Administration sampled 1kg, and now there is 1kg left in stock. The batch number of this batch of Herba Taxilli Chinese herbal pieces is 160501. Inspection by Lanzhou Food and Drug Inspection Institute and re-inspection by Gansu Institute of Drug Inspection showed that the batch number of Chinese traditional medicine decoction pieces of Herba Taxilli produced by our unit was 160501, and the re-inspection results showed that it had the characteristics of mistletoe. I can’t tell the difference between mistletoe and mistletoe, both of which are used medicinal materials. They were originally called mistletoe, and their functions and effects are the same. They are harmless to human body and cannot be distinguished by naked eyes.I am responsible for purchasing all the raw materials for the production of traditional Chinese medicine, and our company has inspected them before releasing them after passing the self-inspection.

　　The court of first instance held that the defendant, Yalan Pharmaceutical Company, had violated the national drug administration laws and regulations by producing and selling counterfeit drugs, which had violated the criminal law and constituted the crime of producing and selling counterfeit drugs, and should be punished according to law. The accusation by the public prosecution agency that the batch number 140201 of Rhizoma Drynariae and the batch number 160501 of Herba Taxilli produced and sold by Yalan Pharmaceutical Company are counterfeit drugs, the facts are clear, the evidence is true and sufficient, and the charges are established, which should be supported. The accusation of the public prosecution agency that the batch number of Qianhu Chinese medicine decoction pieces produced by Yalan Pharmaceutical Company is 160501 is counterfeit is not supported because of insufficient evidence. Defendant Peng, as the head of the third marketing department of Yalan Pharmaceutical Company, is the person directly responsible for purchasing, processing and selling the raw materials of the two batches of Chinese herbal medicines, namely Rhizoma Drynariae and Herba Taxilli, and should be convicted and punished for the crime of producing and selling counterfeit drugs. In view of the fact that the number of fake medicines produced by the defendant unit is small, the description of fake medicine Taxilli is consistent with that of mistletoe, and there is interoperability in clinical use, so the circumstances of the crime are minor, and the defendant unit Yalan Pharmaceutical Company and the defendant Peng Mou can be given a lighter punishment according to law. According to the provisions of Articles 141, 150, 30, 31, 52, 53, 72, 1 and 3, and 73, 1 and 3 of the Criminal Law of People’s Republic of China (PRC), the defendant Gansu Yalan Pharmaceutical Co., Ltd. was convicted of producing and selling counterfeit drugs and fined 10,000 yuan; The defendant Peng was convicted of producing and selling counterfeit drugs and sentenced to six months in criminal detention.Suspended for ten months and fined 5000 yuan.

　　The appellate unit Yalan Pharmaceutical Company and its defenders put forward that the court of first instance decided that Rhizoma Drynariae was a counterfeit drug on the basis of the inspection report issued by Lanzhou Food and Drug Inspection Institute, and the inspection method adopted in this appraisal opinion was wrong, which led to the wrong appraisal conclusion; "Mistletoe" and "Taxilli" are difficult to distinguish in reality, which leads to the company’s inability to distinguish from the purchase to the identification. The company did not intentionally produce counterfeit drugs, and the social harm was not great, so it could not be recognized as counterfeit drugs. It requested to revoke the first-instance judgment and change the verdict to innocence.

　　Appellant Peng proposed that the conclusion of the appraisal opinion of the cannon bone fragments identified by the court of first instance was wrong, and the inspection method on which the appraisal opinion was based was wrong, so the cannon bone fragments involved should not be identified as counterfeit drugs; Because it is difficult to distinguish mistletoe from mistletoe in reality, there is a wrong understanding, and there is no intention to produce and sell counterfeit drugs subjectively; In this case, it is only responsible for purchasing, and the main responsibility should be borne by the quality assurance department; In the whole case, the circumstances are obviously minor, and the harm is not great. As the person in charge of drug procurement, processing and sales, he should not be considered as other directly responsible personnel, and requested to revoke the judgment of first instance and change his sentence to innocence.

　　Defender of Appellant Peng proposed: The basis for the first instance to determine that the batch number of the Chinese herbal pieces of Cannabis Rhizoma Drynariae with batch number of 140201 belongs to counterfeit drugs, that is, there are contradictory appraisal opinions, which is a fact finding error; The appellant did not have the subjective intention to produce and sell "Taxilli" as "Mistletoe", which did not constitute the crime of producing and selling counterfeit drugs; It is doubtful whether this case meets the prosecution standard of the crime of producing and selling counterfeit drugs.

　　The court found that the original judgment found that the appellant Yalan Pharmaceutical Company and the appellant Peng had committed the crime of producing and selling counterfeit drugs, and the evidence was true and sufficient. The listed evidence had been publicly presented, cross-examined and certified in the court of first instance. The court confirmed the facts and evidence found in the first instance according to law, and no new evidence was submitted by the appellant, appellant and defender in the second instance.

　　The appraisal opinions of the appellate unit, the appellant and the defender that the court of first instance identified counterfeit drugs are the reasons for appeal and defense opinions that the inspection method is wrong and cannot be used as the basis for finalizing the case. After investigation, Lanzhou Food and Drug Inspection Institute is a specialized inspection institution with drug inspection qualification. The LZ2015Y2363 inspection report issued by it shows that the inspection result of Rhizoma Drynariae with the batch number of 140201 is not in conformity with the regulations. In view of this inspection report, the appellant did not apply for re-inspection within the effective period, so the inspection result should be considered valid. Lanzhou Food and Drug Administration’s reply to the Application for Identification of Chinese Herbal Pieces such as Rhubarb indicated that the manufacturer of Rhizoma Drynariae (batch No.140201) needs to be verified in order to judge the authenticity of this batch of drugs. If the company has been registered in our province in accordance with relevant laws and regulations, it has the qualification to produce and process Rhizoma Drynariae with big leaves, but it has not been corrected in our province, it will be in accordance with GMP/GSP. If there is no qualification to produce and process "Rhizoma Drynariae with big leaves", it is suggested to treat it as fake medicine. According to the reply of Gansu Drug Administration on this case, Gansu Yalan Pharmaceutical Co., Ltd., the appellant, has the production qualification to produce pieces of Rhizoma Drynariae, and "Rhizoma Drynariae with big leaves" has not been included in China Pharmacopoeia, Gansu Province Chinese Medicine Processing Standard and Gansu Province Chinese Medicine Standard. According to the second paragraph of Article 141 of the Criminal Law, whether it is a counterfeit drug shall be subject to the Drug Administration Law of People’s Republic of China (PRC), and according to the relevant provisions of this law,Chinese herbal pieces must be produced in accordance with the national drug standards and the production technology approved by the drug supervision and administration department of the State Council. If there are no provisions in the national drug standards, they must be processed in accordance with the processing standards formulated by the drug supervision and administration departments of the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government. Drynaria macrophylla is not included in China Pharmacopoeia, Gansu Chinese Medicine Processing Standard and Gansu Chinese Medicine Standard. Therefore, Drynaria macrophylla is not a drug prescribed by the state, and the production and sale of Drynaria macrophylla is a fake drug, which is a non-drug or another drug. Therefore, the appeal reason and the defense opinion put forward by the appellant and the appellant cannot be established.

　　As for the appeal unit, the appellant and the defender, it is difficult to distinguish mistletoe and Taxilli because of reality, and there is no subjective and intentional appeal reason and defense opinion for producing and selling counterfeit drugs. After investigation, the drug inspection report of Lanzhou Food and Drug Inspection Institute and the inspection report of Gansu Drug Inspection Institute confirmed that the "Taxilli" with batch number of 160501 did not meet the requirements, and it had the characteristics of "mistletoe", which belonged to the situation that other drugs passed off as this drug. According to the People’s Republic of China (PRC) Pharmacopoeia, there was a certain difference between "mistletoe" and "Taxilli", indicating that there was an objective possibility to distinguish them. In this case, the Appellant and the Appellant, as professional organizations and personnel with professional knowledge, should have the ability to distinguish between mistletoe and Taxilli, and their inability to distinguish between mistletoe and Taxilli as the subjective and intentional appeal reason and defender for not producing and selling counterfeit drugs cannot be established.

　　Appeal reasons and defense opinions of the appellant and the defender that the case does not meet the prosecution standard for the crime of producing and selling counterfeit drugs, and that the circumstances of the crime are obviously minor and the harm is not great, so it is not suitable for criminal treatment. After investigation, after the implementation of the Criminal Law Amendment (VIII) of People’s Republic of China (PRC), the constitutive elements of the crime of producing and selling counterfeit drugs are no longer required to be "harmful to human body". As a professional, there have been many irregular purchases and sales, and their actions have endangered public health. The actions of the appellant and the appellant have constituted the crime of producing and selling counterfeit drugs and should be punished according to the Criminal Law. The court of first instance combined the criminal motives, subjective intention, objective behavior and social harmfulness of the two appellants, and made a judgment, which was given a lighter sentence within the statutory penalty range, which was an appropriate sentence. Therefore, the appeal reason and the defender’s defense opinion could not be established.

　　As the person in charge of drug procurement, processing and sales mentioned by the appellant Peng and his defenders, it should not be regarded as the appeal grounds and defense opinions of other directly responsible personnel. After investigation, according to the documents of Gansu Yalan Pharmaceutical Co., Ltd., witness testimony and Peng’s confession, Peng, as the director of the marketing department of the sales management center, is responsible for the procurement, processing and sales of raw materials of the department, and is responsible for the supervision and management of the drugs produced and sold. As the directly responsible person in charge, Peng should bear corresponding criminal responsibilities. The grounds for appeal cannot be established.

　　We believe that the facts of the original judgment that the appellant Gansu Yalan Pharmaceutical Co., Ltd. and the appellant Peng Mou committed the crime of producing and selling counterfeit drugs are clear, the evidence is indeed sufficient, the applicable law is correct, the sentencing is appropriate, and the trial procedure is legal. In accordance with the provisions of Article 236, Paragraph 1 (1) and Article 244 of the Criminal Procedure Law of People’s Republic of China (PRC), the ruling is as follows:

　　Reject the appeal and uphold the original judgment.

　　This ruling is final.

　　Presiding judge Zhao Jinrong

　　Judge An Hairong

　　Judge Song Ximin

　　February 25, 2020

　　Judge? Assistant Zhu Yiming

　　Clerk Ren Zixuan

Shengming: This article is reproduced for the purpose of transmitting more information. If the source is marked incorrectly or infringes on your legitimate rights and interests, please contact this website with the ownership certificate, and we will correct and delete it in time. Thank you. Tel: 028-60185688, email: kefu@zyctd.com.

Machine heart report

Editor: Chen Ping, Devil

The training of deep learning model is like "black box operation", knowing what the input is and what the output is, but the intermediate process is like a black box, which makes researchers spend a lot of time to find out why the model is not working properly. It would be great if there is a visual tool that can help researchers better understand the model behavior.

Recently, Google researchers released a language interpretability tool (LIT), which is an open source platform for visualizing and understanding natural language processing models.

Address: https://arxiv.org/pdf/2008.05122.pdf.

Project address: https://github.com/PAIR-code/lit.

LIT focuses on the core issues of model behavior, including: Why does the model make such predictions? When is the performance poor? What happens when the input changes are controllable? LIT integrates local interpretation, aggregation analysis and counterfactual generation into a streamlined browser-based interface to realize rapid exploration and error analysis.

This study supports a variety of natural language processing tasks, including exploring the counterfactual of emotional analysis, measuring gender bias in the coreference system, and exploring local behaviors in text generation.

In addition, LIT also supports a variety of models, including classification, seq2seq and structured prediction models. And it is highly extensible and can be extended through declarative and framework-independent API.

For related demo, see the video:

It can be reconfigured for novel workflow, and these components are independent, portable and easy to implement.

User Interface(UI)

LIT is located in a single-page web application, which consists of multiple toolbars and a main part with multiple independent modules. If modules are applicable to the current model and data set, they will be displayed automatically. For example, the module that displays the classification results is only displayed when the model returns MulticlassPreds.

LIT user interface

The layout design of LIT.

function

LIT supports various debugging workflows through a browser-based user interface (UI). Functions include:

Local interpretation: it is carried out through the saliency map, attention map and rich visualization map predicted by the model.

Aggregation analysis: including user-defined metrics, slicing and binning, and visualization of embedded space.

Counterfactual generation: create and evaluate new examples dynamically by manually editing or generating plug-ins for counterfactual reasoning.

Side-by-side mode: Compare two or more models, or one model based on a pair of examples.

Highly extensible: it can be extended to new model types, including classification, regression, span labeling, seq2seq and language modeling.

Frame-independent: compatible with TensorFlow, PyTorch, etc.

Let’s look at several main modules of LIT:

Exploring data sets: Users can interactively explore data sets using different standards across modules (such as data tables and embedded modules), thus rotating, scaling and translating PCA or UMAP projections to explore clusters and global structures.

Compare models: By loading multiple models in the global settings control, LIT can compare them. Then copy the submodule that displays the information of each model to facilitate the comparison between the two models. Other modules (such as embedded module and measurement module) are updated at the same time to display the latest information of all models.

Compare datapoints: switch to the "Compare data points" button in the selection toolbar to make LIT enter the data point comparison mode. In this mode, the main data point is selected as the reference data point, and it will be used as the reference point for comparison in subsequent settings. Reference data points are highlighted in the data table with a blue border.

See: https://github.com/pair-code/lit/blob/main/docs/user _ guide.md for details of other modules.

After reading the above introduction, are you eager to get started and try this cool visualization tool? Let’s take a look at its installation process and examples.

Installation tutorial

Download the software package and configure Python environment. The code is as follows:

git clone https://github.com/PAIR-code/lit.git ~/lit# Set up Python environmentcd ~/ litconda env create -f environment.ymlconda activate lit-nlpconda install cudnn cupti # optional, for GPU supportconda install -c pytorch pytorch # optional, for PyTorch# Build the frontendcd ~/lit/lit_nlp/clientyarn && yarn build

After installing and configuring the environment, you can experience the examples included in the toolkit.

example

1. Example of emotional classification

The code is as follows:

cd ~/litpython -m lit_nlp.examples.quickstart_sst_demo –port=5432

The example of emotion classification is a fine-tuned BERT-tiny model based on Stanford Emotion Tree Library, which can be completed in less than 5 minutes on GPU. After the training is completed, it will start the LIT server on the development set.

2. Language modeling class example

To explore the prediction results of the pre-training model (BERT or GPT-2), run the following code:

cd ~/litpython -m lit_nlp.examples.pretrained_lm_demo –models=bert-base-uncased –port=5432

For more examples, please refer to the directory: /lit_nlp/examples.

In addition, the project also provides a way to add your own models and data. By creating a customized demo.py launcher, users can easily run LIT with their own models, similar to the above sample directory /lit_nlp/examples.

See: https://github.com/pair-code/lit/blob/main/docs/python _ api.md # adding-models-and-data for the complete adding process.

Reference link:

http://www.iibrand.com/news/202008/1719096.html

https://github.com/PAIR-code/lit/blob/main/docs/user_guide.md

https://github.com/PAIR-code/lit/blob/main/docs/python_api.md#adding-models-and-data

https://medium.com/syncedreview/google-introduces-nlp-model-understanding-tool-ab840b456be3

Amazon SageMaker is a fully hosted service that can help developers and data scientists quickly build, train and deploy machine learning models. SageMaker completely eliminates the heavy work of each step in the machine learning process, making it easier to develop high-quality models.

Now, enterprise developers can get 1000 yuan service vouchers for free, easily get started with Amazon SageMaker, and quickly experience five examples of artificial intelligence applications.

? THE END

Please contact Ben WeChat official account for authorization.

Contribute or seek reports: content@jiqizhixin.com.

Original title: "LIT, Google Open Source NLP Model Visualizer, Model Training is no longer a" black box ""

Read the original text

Justice League

DC and Marvel Comics will finally be "positive" in the mainland market this year.

The release of "Batman v Superman: Dawn of Justice" in 2016 officially announced the opening of the DC movie universe, and the official also announced that many independent superhero works will be put into shooting. The commercial purpose of accelerating the expansion of the film universe is undoubtedly Marvel Comics, which is in full swing and monopolizes the super-British film market.

Judging from the trend in the past two years, DC released three works of Bat Chao almost at the same frequency as Marvel Comics, but the schedule of the mainland and the works of Marvel Comics released at the same time were staggered for more than a month.

Captain America: Civil War May 6, 2016 & mdash; — Batman v Superman: Dawn of Justice, March 25th, 2016.

Galaxy Guard 2, May 5, 2017 & mdash; — Wonder Woman, June 2, 2017

Thor: Ragnarok, November 3, 2017 & mdash; — Justice League November 17, 2017

Until today’s simultaneous release in China (hereinafter referred to as "Zhenglian"), the domestic audience finally waited for DC and Marvel Comics to look back.　

As DC’s first "superhero group" work, it is only less than two weeks away from Marvel Comics’s Thor: Ragnarok release. When two topical works meet, it’s hard for the audience not to compare which is better or worse, and fans in Marvel Comics and DC at home and abroad also started fighting on social media early. However, the staff of the two companies hold an inclusive attitude towards such healthy competition.

　James gunn, director of "Silver Guard" series, admits that he actually likes DC’s works very much.

　President Marvel Comics came out to "persuade the fans"

　Goddess Gado said in an interview that she likes Marvel Comics’s works.

　"Super Super" Henry Cavill: The roles of both sides should be respected.

So, as a loyal fan of superhero movies, Xiao Bian advises you: there is no need to compare too much. After all, there is no distinction between high and low justice.

Judging from the style of Bat Chao, every key work of DC must be full of eggs, and it is also painstaking to pave the way for future works and accumulate popularity. After watching the movie at the first time, Xiaobian summed up these small details that you got or didn’t get. From the numerous hints given by the government, we can even see the story trend of the future DC movie universe.

1 "Maybe more than six chairs"

Justice League has a large number.

Although all kinds of materials advertised in the new film are all under the banner of the Big Five, fortunately, our "Super Super" has officially come back in Zhenglian. With the growth of DCEU, as the female Xia said at the end of the story when the master designed the headquarters of Zhenglian, "Maybe there are more than six chairs". Obviously, this line is intentional by the screenwriter, which implies that more new members will join the Justice League in the future. So who will it be?

The Justice League in the cartoon has as many people as The Avengers in Marvel Comics. However, once it is made into a movie, the number of places will be limited, and the film side has no energy to take care of so many super English. Therefore, if you want to come first, it is hoped that these people will join first from the new work.

— — Green Lantern

Green Lantern

After Ryan Reynolds’s success in Marvel Comics’s "Deadpool", DC must be even more upset about the double loss of popularity of the old version of "The Green Lantern" starring him, so he put the shooting plan of "The Green Lantern Corps" on the agenda early. In Zheng Lian, the green light warrior also appeared in the first invasion of the earth by the wild wolf: in the human phalanx that fought back against Parademons’s army, it was the early green light man who used the green ring to fight.

　

Green Lantern Corps

The difference between the Green Lantern and other superheroes is that the title of "Green Lantern" refers not only to a certain person, but to a group. In the Green Lantern Corps, every soldier wears an energy ring, and the intensity of the energy released depends on the willpower of the soldier himself. It can be said that it is a super weapon without an upper limit. Therefore, with this power, the Green Lantern can naturally rank among the Zhenglian.

— — Shazam

In the ancient war, do you remember the strong man who released lightning with his hands? He is wonder woman’s father Zeus.

Although the Greek gods only appeared in ancient times, some people in the Orthodox League also inherited their abilities, that is, the superhero Shazam, who has exposed that he is about to make a film version.

　

Comic editionShazam

"Shazam" is the title of wizards who fight evil, which has been handed down from generation to generation. The man who fought in the first invasion of the Wilderness Wolf was probably the earliest wizard in history, that is, the first person to use the name "Shazam". The wizard signed a contract with the gods and was given the powerful magical power of the Greek gods. He can also release magic lightning like Zeus.

According to foreign media rumors, the first Shazam of DC will be played by Zachary Levi (this brother also played Thor: Ragnarok & HELLIP; … )

　

Zachary Levi

But his old enemy "Black Adam" — — As a wizard with the same magical power as Shazam, this villain will be played by the actor "Boulder" Qiang Sen, who is extremely popular in recent years.

(The picture shows netizens making their own, unofficial)

Next page: Flash’s parents

　　Editor’s Note: The report of the 19th National Congress of the Communist Party of China put forward the general requirements for Party building in the new era, and strategically pointed out the direction of Party building in the new era. What kind of party should we build and how to build it in the new era? The general requirements put forward the purpose, policy, main line, overall layout and objectives of party building in the new era. Qiushi. com plans to launch a special topic to deeply interpret the specific contents of these five aspects and their relationships for you. Let’s look at them together ↓ ↓

　　1. What are the five basic connotations of the general requirements?

　　1. Purpose: To uphold and strengthen the overall leadership of the Party.

　　At the beginning of the general requirements, it is clearly stated that we should "uphold and strengthen the overall leadership of the Party" and point out the purpose and fundamental principles of Party building in the new era. Party leadership is the "anchor needle" to overcome all difficulties and risks, and it must be comprehensive and holistic. Any field, aspect and link that is missing or weakened will weaken the Party’s strength and harm the cause of the Party and the people.

　　2. Guiding principle: Adhere to the Party’s management of the Party and strictly manage the Party in an all-round way.

　　The general requirements specify the guiding principle of Party building, that is, "Insist on the Party’s management of the Party and strictly manage the Party in an all-round way", and that "China’s problems will come from within communist party". If the Party’s management is weak and lax, the Party will inevitably be eliminated by history and its historical mission will not be realized.

　　3. Main line: Strengthen the construction of the Party’s long-term ruling ability, advancement and purity.

　　The general requirements put forward that "strengthening the construction of the Party’s long-term ruling ability, progressiveness and purity is the main line", which profoundly shows that improving the Party’s ruling ability and leadership level and maintaining the Party’s advanced and purity will always be on the road, which will inevitably accompany the whole process of our Party’s ruling and the magnificent journey of Socialism with Chinese characteristics.

　　4. Overall layout: "5+2"

　　The general requirements further clarify the overall layout of party building, emphasizing "comprehensively promoting the party’s political construction, ideological construction, organizational construction, work style construction and discipline construction, and deepening the anti-corruption struggle through the system construction", grasping the key of party building in the new era, and highlighting the leading position of political construction and discipline construction, which is the fundamental strategy for managing the party and governing the party.

　　5. Goal: Five sentences

　　The general requirements set the party’s construction goal in the new era, that is, "to build the party into a Marxist ruling party that is always in the forefront of the times, wholeheartedly supported by the people, brave in self-revolution, able to stand the test of all kinds of storms, and full of vigor and vitality", which embodies the nature, purpose and program of the party and the value orientation, political determination and mission responsibility of the Communist Party of China (CPC) people in the new era.

　　Second, what is the relationship between the five basic connotations of the general requirements?

　　The general requirements constitute a scientific and organic whole of Party building in the new era. The purpose, policy, main line, overall layout and objectives of Party building in the new era are closely related, interactive and mutually promoting.

　　1. Purpose

　　The purpose is the basis and the fundamental point, and the party building should be carried out closely around this purpose, and it should not be separated or deviated at all times.

　　2. Policy

　　The policy is principle and compliance, which leads the party’s construction in the right direction.

　　3. Main line

　　The main line is the outline and the soul. The outline is open and the soul is here.

　　4. Overall layout

　　The overall layout is the key point and the path. When the overall layout is established, the party building will have solid support and a strong grasp.

　　5. Objectives

　　The goal is the direction and the foothold, and all the work of party building should be strengthened towards this goal and tested according to this goal.